Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2024-05-07 | Alzinova | Alzinova publishes the Annual Report for 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-05-07 | Alzinova | Alzinova publicerar årsredovisningen för 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-05-06 | Alzinova | BioStock: Alzinovas avgående vd kommenterar bolagets potential | Pressreleaser | Visa Stäng |
|
||||
2024-04-26 | Alzinova | KALLELSE TILL ÅRSSTÄMMA I ALZINOVA AB (PUBL) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-26 | Alzinova | NOTICE OF ANNUAL GENERAL MEETING IN ALZINOVA AB (PUBL) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-26 | Alzinova | The Board of Directors resolves on a rights issue of shares of approximately SEK 34.4 million | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-26 | Alzinova | Styrelsen beslutar om en företrädesemission av aktier om cirka 34,4 MSEK | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-25 | Alzinova | Kristina Torfgård lämnar VD-posten på Alzinova AB i juli 2024 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-25 | Alzinova | Kristina Torfgård leaves the CEO position at Alzinova AB in July 2024 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-22 | Alzinova | BioStock: Alzinovas CSO kommenterar nya analysdata för ALZ-101 i Alzheimers sjukdom | Pressreleaser | Visa Stäng |
|
||||
2024-04-11 | Alzinova | Alzinova: Fördjupad analys påvisar positiv trend för biomarkörer | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-11 | Alzinova | Alzinova: In-depth analysis shows positive trend in biomarkers | Pressreleaser | Ladda ner | Visa Stäng |
Pressreleaser |
Alzinova: In-depth analysis shows positive trend in biomarkersAlzinova AB (publ) (ticker: ALZ) announces today that an in-depth analysis of data from part A of Alzinova’s phase 1b study with the vaccine candidate ALZ-101 has been completed. The analysis indicates that patients with the higher antibody levels after vaccination show a positive effect on biomarkers associated with Alzheimer’s disease. This analysis provides an increased understanding of ALZ-101, which is promising in Alzinova’s preparations for the phase 2 study and when the company evaluates a higher dose in parallel. “From these new analyses, we see promising results that indicate that there are patients who already after 16 weeks of treatment with our vaccine candidate respond positively to biomarkers related to Alzheimer’s disease. This feels fantastic and we are now looking forward to the upcoming evaluation of longer treatment time and higher dose with ALZ-101. The result is also important in our partner dialogues and preparations for the phase 2 study.”, says Alzinova’s CEO Kristina Torfgård. Since January 2024, when Alzinova announced positive results from the primary analysis of the phase 1b study with the vaccine candidate ALZ-101 against Alzheimer’s, further analyses of the study data have been conducted. In the analyses, the company has examined exploratory endpoints, such as biomarkers related to the disease, which are important as they may indicate a potential effect of the drug. The results of the new analyses indicate a positive change in biomarkers in the cerebrospinal fluid of the patients who showed high antibody levels, so-called immune responses, during part A of the study. The change has been identified already after 16 weeks of treatment with four doses of ALZ-101. The company plans to continue to follow up and analyse the biomarkers after treatment with a higher dosein part A2 and for a longer period of timein part B of the study. ”The results from Alzinova’s analysis of biomarkers in the phase 1b study are very promising. The fact that we can observe an effect on biomarkers in the spinal fluid suggests that the vaccine has a therapeutic effect. I believe in Alzinova’s development of a drug that targets the toxic accumulations of amyloid known as oligomers, and I look forward to the results of upcoming clinical studies on the vaccine candidate.”, says Henrik Zetterberg, professor of neurochemistry at the University of Gothenburg and University College London and scientific advisor to Alzinova. The results are planned to be presented at upcoming international medical conferences. About ALZ-101 and Alzheimer’s disease Alzinova’s approach of developing vaccine and antibody treatments that specifically target the toxic accumulations of amyloid-beta in the form of oligomers in the brain, has several advantages over other approaches. Other treatments target larger accumulations of amyloid-beta, known as plaques in the brain, which are believed to contain both toxic and harmless proteins. Alzinova has developed a method that could specifically target the brain’s toxic amyloid-beta oligomers, one of the underlying causes of Alzheimer’s disease. Vaccination with ALZ-101 involves the body generating its own antibodies, specific to toxic accumulations of amyloid-beta oligomers in the brain. These toxic substances are expected to be neutralised, thus protecting the brain’s synapses from damage, which could slow or prevent the development of Alzheimer’s disease. The treatment method is also expected to have a lower risk of side effects such as brain oedema. The company therefore believes that it is likely to be more successful than other broader approaches to Alzheimer’s disease. |
||||
2024-04-10 | Alzinova | BioStock: Alzinova når ytterligare milstolpe i Alzheimerstudie | Pressreleaser | Visa Stäng |
|
||||
2024-04-04 | Alzinova | Alzinova - All patients in the extension part of the phase 1b study have received their last dose | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-04 | Alzinova | Alzinova - Samtliga patienter i fas 1b-studiens förlängningsdel har fått sin sista dos | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-08 | Alzinova | Alzinova appoints Erik Kullgren as interim CFO | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-08 | Alzinova | Alzinova utser Erik Kullgren som interim CFO | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-05 | Alzinova | Alzinova presents at investor meetings in March | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-05 | Alzinova | Alzinova presenterar på investerarträffar i mars | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-04 | Alzinova | BioStock: Alzinova siktar på partnerskap för Alzheimerstudien | Pressreleaser | Visa Stäng |
|
||||
2024-02-29 | Penser Future by Carnegie | Penser Future by Carnegie: Alzinova - Huvudfokus för 2024 är att teckna ett partneravtal | Pressreleaser | Visa Stäng |
|
||||
2024-02-28 | Redeye | Redeye: Alzinova Q4 – With wind in the sails | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-28 | Alzinova | Alzinova publishes Year-end report 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-02-28 | Alzinova | Alzinova offentliggör bokslutskommuniké för 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-02-16 | Alzinova | BioStock: Alzinova får grönt ljus att öka dosen i Alzheimerstudie | Pressreleaser | Visa Stäng |
|
||||
2024-02-13 | Alzinova | Alzinova får myndighetsgodkännande att utvärdera en högre dos | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-13 | Alzinova | Alzinova receives regulatory approval to evaluate a higher dose | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-07 | Alzinova | Alzinova till BioStock: "Vi har ett starkt case med vår Alzheimerkandidat" | Pressreleaser | Visa Stäng |
|
||||
2024-01-30 | Alzinova | Alzinova: Primär analys bekräftar positiva fas 1b-resultat med ALZ-101 mot Alzheimers | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-30 | Alzinova | Alzinova: Primary analysis confirms positive phase 1b results with ALZ-101 against Alzheimer’s | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-08 | Alzinova | BioStock: Alzinova's CMO wants to bring forward a vaccine against Alzheimer's | Pressreleaser | Visa Stäng |
|
||||
2023-12-11 | Penser Future by Carnegie | Penser Future by Carnegie: Alzinova - Therapeutic Alzheimer's vaccine in the spotlight | Pressreleaser | Visa Stäng |
|
||||
2023-12-07 | Penser Future by Carnegie | Penser Future by Carnegie: Intervju med Alzinova - Carnegie Investment Bank - 7 dec 2023 | Pressreleaser | Visa Stäng |
|
||||
2023-12-04 | Alzinova | BioStock: Alzinovas vd kommenterar positiva topline-data | Pressreleaser | Visa Stäng |
|
||||
2023-12-04 | Redeye | Redeye: Alzinova - Positive topline results | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-12-01 | Penser Future by Carnegie | Penser Future by Carnegie: Positiva topline-resultat från den kliniska fas Ib-studien - Alzinova | Pressreleaser | Visa Stäng |
|
||||
2023-12-01 | Alzinova | Alzinovas CFO avser gå i pension och Bolaget inleder rekryteringsprocessen för en efterträdare | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-12-01 | Alzinova | Alzinova's CFO plans for retirement and the Company initiates a recruitment process for a successor | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-29 | Alzinova | Alzinova meddelar positiva fas 1b-resultat med vaccinkandidaten ALZ-101 mot Alzheimers sjukdom | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-29 | Alzinova | Alzinova announces positive phase 1b results with the vaccine candidate ALZ-101 against Alzheimer's disease | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-21 | Penser Future | Penser Future: Terapeutiskt vaccin mot Alzheimers sjukdom i fokus - Alzinova AB | Pressreleaser | Visa Stäng |
|
||||
2023-11-20 | Alzinova | Alzinova presenterar på Erik Penser Banks Bolagsdag den 23 november | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-20 | Alzinova | Alzinova presents at Erik Penser Bank's Investor Day on November 23rd | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-06 | Alzinova | BioStock: Alzinova om förväntningarna inför BIO-Europe | Pressreleaser | Visa Stäng |
|
||||
2023-11-02 | Redeye | Redeye: Alzinova Q3 - All eyes on the readout | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-02 | Alzinova | Alzinova AB delårsrapport för januari - september 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-11-02 | Alzinova | Alzinova AB interim report January – September 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-10-24 | Alzinova | Alzinova engages Erik Penser Bank as liquidity provider | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-24 | Alzinova | Alzinova anlitar Erik Penser Bank som likviditetsgarant | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-05 | Alzinova | Alzinova deltar under hösten vid Europas största Life science-konferens och investerarträffar | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-05 | Alzinova | Alzinova will attend Europe's largest Life Science conference and investor meetings this fall | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-28 | Alzinova | BioStock: Alzinova säkrar regulatoriskt stöd från EMA | Pressreleaser | Visa Stäng |
|
||||
2023-09-26 | Alzinova | Alzinova receives positive response from the European Medicines Agency EMA | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-26 | Alzinova | Alzinova erhåller positivt svar från European Medicines Agency EMA | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-21 | Alzinova | Alzinova interviewed by Redeye in connection with World Alzheimer's Day | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-21 | Alzinova | Alzinova intervjuas hos Redeye i samband med World Alzheimer’s Day | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-11 | Alzinova | BioStock: Alzinovas vd sammanfattar 2023 och blickar framåt | Pressreleaser | Visa Stäng |
|
||||
2023-08-25 | Alzinova | Alzinova inleder samarbete med PolyPeptide | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-25 | Alzinova | Alzinova initiates collaboration with PolyPeptide | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-17 | Redeye | Redeye: Alzinova Q2 2023 - Proactive preparations | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-17 | Alzinova | Alzinova AB delårsrapport för januari - juni 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-08-17 | Alzinova | Alzinova AB interim report January – June 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-08-10 | Alzinova | BioStock: Alzinova meddelar positiva samtal med FDA | Pressreleaser | Visa Stäng |
|
||||
2023-08-09 | Alzinova | Alzinova progresses following positive Pre-IND meeting with FDA | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-09 | Alzinova | Alzinova avancerar efter positivt Pre-IND-möte med FDA | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-03 | Alzinova | Alzinova recruits Kirsten Harting as new Chief Medical Officer | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-03 | Alzinova | Alzinova rekryterar Kirsten Harting som ny Chief Medical Officer | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-16 | Alzinova | BioStock: Alzinovas vd om kontakterna med FDA och EMA - BioStock | Pressreleaser | Visa Stäng |
|
||||
2023-06-13 | Alzinova | Alzinova submits request for Pre-IND meeting with FDA and applies for EMA Scientific Advice | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-13 | Alzinova | Alzinova ansöker om Pre-IND möte med FDA och EMA Scientific Advice | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-30 | Alzinova | Kommuniké från årsstämma i Alzinova AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-30 | Alzinova | Bulletin from the annual general meeting of Alzinova AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-29 | Alzinova | Första patienten doserad i förlängningsdelen av fas 1b studien med ALZ-101 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-29 | Alzinova | First patient dosed in the extension part of the phase 1b study with ALZ-101 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-17 | Redeye | Redeye: Alzinova Q1 2023 - Promising clinical progress | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-17 | Alzinova | Alzinova AB interim report January – March 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-05-17 | Alzinova | Alzinova AB delårsrapport för januari - mars 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-05-10 | Alzinova | BioStock: Fortsatt robusta interimdata i Alzinovas Alzheimerstudie | Pressreleaser | Visa Stäng |
|